Matthew B. Laurens, MD, discusses the safety and immunogenicity of the typhoid conjugate vaccine among children living in areas with a high disease burden.
Matthew D. Taylor, MD, provides insight into the potential effects of angiotensin II on bacterial clearance and the systemic inflammatory response in clinical sepsis.
Lisa Winston, MD; Ryan Miller, DO; and Neha Nanda, MD, discuss measures to reduce the spread of health care-associated Clostridioides difficile infection.
In addition to worsening asthma, other respiratory disorders, and heart conditions, exposure to wildfire smoke can also compromise immunity in healthy individuals.
Dr Alissa Davis, an Epidemiologist at Columbia University, discusses steps to contain the monkeypox outbreak, including the importance of appropriate messaging and addressing misinformation.
Karen Krueger, MD, provides insight into the role Infectious Disease providers can play in the World Health Organization’s recently announced Global Arborvirus Initiative.
To help relieve excruciating anorectal symptoms from monkeypox, clinicians in the United States are prescribing tecovirimat, though in short supply, and recommending OTC treatments.
Researchers described the effects of oral tecovirimat treatment in 2 men with monkeypox virus-associated severe proctitis.